Werewolf Therapeutics Receives Fast Track Designation from the U.S. FDA for WTX-124, an Investigational Therapy for the Treatment of Cancer Biotech Investing
ARS Pharmaceuticals Receives Favorable Decision from European Patent Office on Patent Related to neffy® Biotech Investing
AbCellera to Participate at Upcoming Investor Conferences in November and December 2025 Biotech Investing
Clinical Breakthroughs Converge as Immunotherapy Market Surges Past $136 Billion Life Science Investing
Nautilus Biotechnology to Announce Third Quarter 2025 Financial Results on October 28, 2025 Biotech Investing
Arrowhead Pharmaceuticals Files CTA for Investigational ARO-DIMER-PA - the First Dual Functional RNAi Therapeutic for the Treatment of Mixed Hyperlipidemia Biotech Investing
